Equities

Bioventix PLC

BVXP:LSE

Bioventix PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)4,375.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.89k
  • 1 Year change17.45%
  • Beta0.2739
Data delayed at least 20 minutes, as of May 16 2024 16:10 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue131211
OPERATING EXPENSES
Cost of revenue total0.830.710.82
Selling, general and admin. expenses, total1.941.851.76
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total(0.03)(0.02)(0.03)
Total operating expense2.782.452.84
Operating income109.278.09
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes109.288.12
Provision for income taxes1.761.601.39
Net income after taxes8.377.676.73
Minority interest------
Net income before extra. Items8.377.676.73
Total extraordinary items------
Net income8.377.676.73
Inc.avail. to common excl. extra. Items8.377.676.73
Inc.avail. to common incl. extra. Items8.377.676.73
EPS RECONCILIATION
Basic/primary weighted average shares5.215.215.21
Basic/primary eps excl. extra items1.611.471.29
Basic/primary eps incl. extra items1.611.471.29
Dilution adjustment--0--
Diluted weighted average shares5.295.265.26
Diluted eps excl. extra items1.581.461.28
Diluted eps incl. extra items1.581.461.28
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.521.261.43
Gross dividend - common stock--7.927.71
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental00.00--
SUPPLEMENTAL INCOME
Depreciation, supplemental0.130.140.14
Total special items------
NORMALISED INCOME
Normalized income before taxes109.288.12
Effect of special items on income taxes------
Income tax excluding impact of special items1.761.601.39
Normalized income after tax8.377.676.73
Normalized income avail. to common8.377.676.73
Basic normalized EPS1.611.471.29
Diluted normalized EPS1.581.461.28
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.